Literature DB >> 27883254

The degree of extramural spread of T3 rectal cancer: an appeal to the American Joint Committee on Cancer.

R Zinicola1, G Pedrazzi2, N Haboubi3, R J Nicholls4.   

Abstract

The T3 category of the TNM classification includes over 60% of all rectal tumours and encompasses the greatest variance in cancer-specific end-points than any other T category. The most recent edition of the cancer staging handbook of the American Joint Committee on Cancer (AJCC) dated 2010 does not divide T3 tumours into subgroups which reflect cancer-specific outcome more sensitively. The original aim of the present study was to review the literature to assess the influence of the degree of extramural extent of T3 rectal cancer on local recurrence and survival. An article written by the authors was accepted for publication but was withdrawn immediately after they became aware of the publication of the 4th edition of the TNM Supplement by the Union for International Cancer Control dated 2012, which was not accessible by the search system used. This article dealt with the subdivision of the T3 category although this was not included in the most up-to-date AJCC guidelines and was stated to be 'entirely optional'. Medline, PubMed and Cochrane Library searches were performed to identify all studies that investigated the degree of extramural spread and its relationship to survival and local recurrence. Twenty-two studies were identified of which 12 assessed the degree of histopathological extramural spread measured in millimetres. In 18 of the 22 studies the degree of extramural spread was a statistically significant prognostic factor for survival and local recurrence. Analysis of the studies indicated that the subdivision of category T3 rectal cancer into two subgroups of extramural spread ≤ 5 mm or more than 5 mm resulted in markedly different survival and local recurrence rates. The data were insufficient to allow validation of any greater subdivision. Measurement of the extent of extramural spread by MRI before any treatment agreed with the histopathological measurement in the surgical specimen to within 1 mm. The extent of extramural spread in T3 rectal cancer measured in millimetres is a powerful prognostic factor. A subdivision of T3 into T3a and T3b of less than or equal to or more than 5 mm appears to give the greatest discrimination of local recurrence and survival. Preoperative T3 subdivision by MRI has the same sensitivity as histopathological examination of the resected specimen. Given the clinical need for the pretreatment classification of the T3 category for oncological management planning, the evidence strongly indicates that the subdivision of the T3 category by MRI should be formally considered as part of the TNM staging system for rectal cancer. Colorectal Disease
© 2016 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Mesh:

Year:  2017        PMID: 27883254     DOI: 10.1111/codi.13565

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  9 in total

1.  Extramural venous invasion and depth of extramural invasion on preoperative CT as prognostic imaging biomarkers in patients with locally advanced ascending colon cancer.

Authors:  Jungheum Cho; Young Hoon Kim; Hae Young Kim; Won Chang; Ji Hoon Park
Journal:  Abdom Radiol (NY)       Date:  2022-09-06

2.  A Modified Classification of Prognostic Factors Based on Pathological Stage and Tumor Regression Grade in Patients with Rectal Cancer Who Receive Preoperative Chemoradiotherapy.

Authors:  Toshiyuki Suzuki; Sotaro Sadahiro; Akira Tanaka; Kazutake Okada; Gota Saito; Hiroshi Miyakita; Takeshi Akiba; Hiroshi Yamamuro
Journal:  Oncology       Date:  2017-07-21       Impact factor: 2.935

3.  T3 subclassification using the EMD/mesorectum ratio predicts neoadjuvant chemoradiation outcome in T3 rectal cancer patients.

Authors:  Lijun Shen; Yiqun Sun; Hui Zhang; Jing Zhang; Weijuan Deng; Yaqi Wang; Ye Yao; Lifeng Yang; Ji Zhu; Tong Tong; Liping Liang; Zhen Zhang
Journal:  Br J Radiol       Date:  2017-11-21       Impact factor: 3.039

4.  Report from the 20th annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; 28-29 September 2018.

Authors:  D M Le; S Ahmed; S Ahmed; B Brunet; J Davies; C Doll; M Ferguson; N Ginther; V Gordon; T Hamilton; P Hebbard; R Helewa; C A Kim; R Lee-Ying; H Lim; J M Loree; J P McGhie; K Mulder; J Park; D Renouf; R P W Wong; A Zaidi; T Asif
Journal:  Curr Oncol       Date:  2019-12-01       Impact factor: 3.677

5.  Clinical significance of invasion distance relative to prognosis in pathological T3 colorectal cancer.

Authors:  Masatoshi Nomura; Hidekazu Takahashi; Makoto Fujii; Norikatsu Miyoshi; Naotsugu Haraguchi; Taishi Hata; Chu Matsuda; Hirofumi Yamamoto; Tsunekazu Mizushima; Masaki Mori; Yuichiro Doki
Journal:  Oncol Lett       Date:  2019-09-24       Impact factor: 2.967

6.  Clinical significance of the EMD/mesorectum ratio of T3 mid-low rectal cancer: A retrospective observational study.

Authors:  Chaoyang Gu; Xuyang Yang; Xubing Zhang; Erliang Zheng; Xiangbing Deng; Tao Hu; Qingbin Wu; Liang Bi; Bing Wu; Minggang Su; Ziqiang Wang
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

7.  SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021).

Authors:  Jaume Capdevila; Ma Auxiliadora Gómez; Mónica Guillot; David Páez; Carles Pericay; Maria José Safont; Noelia Tarazona; Ruth Vera; Joana Vidal; Javier Sastre
Journal:  Clin Transl Oncol       Date:  2022-03-18       Impact factor: 3.340

8.  Comparison of Computed and Acquired DWI in the Assessment of Rectal Cancer: Image Quality and Preoperative Staging.

Authors:  Yihan Xia; Lan Wang; Zhiyuan Wu; Jingwen Tan; Meng Fu; Caixia Fu; Zilai Pan; Lan Zhu; Fuhua Yan; Hailin Shen; Qianchen Ma; Gang Cai
Journal:  Front Oncol       Date:  2022-03-18       Impact factor: 6.244

9.  Texture Analysis in the Assessment of Rectal Cancer: Comparison of T2WI and Diffusion-Weighted Imaging.

Authors:  Ming Li; Xiaodan Xu; Pengjiang Qian; Heng Jiang; Jianlong Jiang; Jinbing Sun; Zhihua Lu
Journal:  Comput Math Methods Med       Date:  2021-09-15       Impact factor: 2.238

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.